Latest Prescription Drugs news
SGLT2 Inhibitor Use May Benefit Patients With HFpEF
posted December 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Further Study Needed for Teriflunomide in Children With Relapsing MS
posted December 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: Modified Regimen Slows Diffuse Large B-Cell Lymphoma
posted December 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pfizer Says Final Data Show COVID-19 Pill Stays Strong Against Severe Illness
posted December 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus Monthly Specialist Briefings
Stay Connected
